Financhill
Back

Perspective Therapeutics Vs. Kewaunee Scientific Industry Stock Comparison

Sell
31

CATX
Perspective Therapeutics

Last Price:
13.91
Seasonality Move:
-10.19%
Sell
45

KEQU
Kewaunee Scientific

Last Price:
39.11
Seasonality Move:
-4.4%
Sell
31
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $13.35. The Score for CATX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Kewaunee Scientific (KEQU) is a Sell

Is Kewaunee Scientific a Buy, Sell or Hold?

  • The current Kewaunee Scientific [KEQU] share price is $38.58. The Score for KEQU is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • KEQU is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $13.35
    The current trend is relatively stagnant and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

KEQU Stock Price Chart

What is Kewaunee Scientific's stock price today?

  • The Kewaunee Scientific share price today is $38.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KEQU is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.08 Buy
Relative Strength Index (14 RSI): 41.91 Sell
Chaikin Money Flow: -533654 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.94 - 15.76) Sell
Bollinger Bands (100): (11.54 - 15.98) Sell

KEQU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.27 Sell
Relative Strength Index (14 RSI): 31.2 Sell
Chaikin Money Flow: 13533 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.07 - 53.97) Sell
Bollinger Bands (100): (38.01 - 50.83) Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.73 Sell
20-day SMA: 15.07 Sell
50-day SMA: 13.7 Sell
200-day SMA: 11.22 Buy
8-day EMA: 14.29 Sell
20-day EMA: 14.54 Sell
50-day EMA: 13.97 Sell
200-day EMA: 11.48 Buy

KEQU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.11 Sell
20-day SMA: 47.82 Sell
50-day SMA: 49.15 Sell
200-day SMA: 36.95 Buy
8-day EMA: 40.71 Sell
20-day EMA: 45.01 Sell
50-day EMA: 46.59 Sell
200-day EMA: 38.13 Buy

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.08 per share.

Kewaunee Scientific Earnings Growth & KEQU Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kewaunee Scientific Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):